Edwards Lifesciences Corp
NYSE:EW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edwards Lifesciences Corp
NYSE:EW
|
US |
|
B
|
Bidvest Group Ltd
XMUN:NQL1
|
ZA |
|
B
|
Bandai Namco Holdings Inc
XMUN:N9B
|
JP |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
R
|
RWE AG
F:RWE
|
DE |
|
Hyundai Motor Co
KRX:005380
|
KR |
|
B
|
Bank of Communications Co Ltd
XMUN:C4C
|
CN |
|
L
|
Lonza Group AG
XMUN:LO3
|
CH |
|
Mettler-Toledo International Inc
NYSE:MTD
|
US |
|
L
|
Lloyds Banking Group PLC
DUS:LLD
|
UK |
|
C
|
Chayo Group PCL
SET:CHAYO
|
TH |
|
A
|
argenx SE
F:1AE
|
NL |
|
FIRST BANK (Hamilton)
F:6UT
|
US |
|
Ke Holdings Inc
F:KE8A
|
CN |
|
J
|
Jabil Inc
XBER:JBL
|
US |
Wall St Price Targets
EW Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EW is 97.95 USD with a low forecast of 85.85 USD and a high forecast of 115.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EW's stock price target?
Price Target
97.95
USD
According to Wall Street analysts, the average 1-year price target for EW is 97.95 USD with a low forecast of 85.85 USD and a high forecast of 115.5 USD.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 27%.
